abstract |
Methods for treating inflammatory neurodegenerative diseases, or at least one symptom thereof, are provided in a subject by the administration of a therapeutic composition comprising at least one electrokinetically altered fluid (e.g., electrokinetically generated oxygen-enriched fluids) of the present. invention. Particular aspects provide methods to inhibit and / or modulate the function and / or activity of effector T cells, and / or for cell-based tolerogenic therapy. In certain aspects such methods comprise the ex vivo exposure of T cells and / or APC to at least one electrocintically altered fluid as described in the present description. In addition, combination therapies are provided. |